6/9/2010

The FDA has given the green light to the University of Alabama, Birmingham, to use its Repetitive Transcranial Magnetic Stimulation device for the treatment of patients who have failed to respond to antidepressant drugs. The rTMS device works by delivering MRI-strength magnetic pulses to the brain.

Related Summaries